<p>根據 Armstrong Henry H Associates Inc.在最近向證券交易委員會提交的 13F 文件，該公司在第三季度將其在沃特世（NYSE:WAT - 免費報告）股份的持倉削減了 47.7%。該機構投資者在此期間出售了 3,889 股後，持有 4,268 股該醫療儀器供應商的股票。Armstrong Henry H Associates Inc.在沃特世的持股在最近的報告期末價值為 1,280,000 美元。</p>
<ul>
<li>安捷倫科技受益於對永久化學品的打擊</li>
</ul>
<p>其他機構投資者最近也增加或減少了在該公司的股份。先鋒集團在第二季度將其在沃特世的持倉提高了 1.9%。先鋒集團目前持有 7,410,763 股該醫療儀器供應商的股票，價值為 2,586,653,000 美元，此前在上個季度又購買了 138,511 股。Alliancebernstein L.P.在第二季度將其在沃特世的股份提高了 31.0%。Alliancebernstein L.P.目前持有 4,021,358 股該醫療儀器供應商的股票，價值為 1,403,615,000 美元，此前在上個季度又收購了 950,687 股。道富銀行在第二季度將其在沃特世的持股提高了 1.4%。道富銀行目前持有 2,676,198 股該醫療儀器供應商的股票，價值為 934,100,000 美元，此前在上個季度又購買了 37,763 股。Geode Capital Management LLC 在第二季度將其在沃特世的股份提高了 2.8%。Geode Capital Management LLC 目前持有 1,552,399 股該醫療儀器供應商的股票，價值為 539,606,000 美元，此前在上個季度又購買了 42,202 股。最後，挪威銀行在第二季度購買了沃特世的新股份，價值約為 266,384,000 美元。機構投資者和對沖基金持有該公司 94.01% 的股份。</p>
<h2>沃特世股票表現</h2>
<p>沃特世股票週二開盤價為 385.31 美元。沃特世的 1 年最低價為 275.05 美元，1 年最高價為 423.56 美元。該股票的市值為 229.4 億美元，市盈率為 35.41，PEG 比率為 3.50，貝塔值為 1.16。該公司的債務與股本比率為 0.41，速動比率為 1.08，流動比率為 1.53。該股票的 50 日移動平均線為 369.47 美元，200 日移動平均線為 333.65 美元。</p>
<ul>
<li>醫療股票沃特世、安捷倫、Illumina 顯示增長潛力</li>
</ul>
<p>沃特世（NYSE:WAT - 獲取免費報告）最近在 5 月 19 日星期四發佈了季度財報。該醫療儀器供應商報告本季度每股收益為 2.29 美元。該業務本季度的收入為 6.0855 億美元。沃特世的淨利潤率為 20.89%，股本回報率為 36.59%。研究分析師平均預測沃特世將在本年度發佈 12.86 的每股收益。</p>
<h2>分析師設定新目標價</h2>
<p>幾位股票分析師最近對 WAT 股票發表了評論。羅斯柴爾德紅寶石在 10 月 8 日星期三的研究報告中將沃特世的評級上調至 “強力買入”。摩根士丹利在 12 月 1 日星期一的報告中開始覆蓋沃特世的股票。他們為該公司設定了 “持平” 的評級和 423.00 美元的目標價。TD Cowen 在 11 月 5 日星期三的研究報告中將沃特世的目標價從 345.00 美元上調至 390.00 美元，並給予該公司 “持有” 評級。Redburn Partners 在 10 月 8 日星期三的研究報告中為沃特世設定了 390.00 美元的目標價。最後，Cowen 在 11 月 5 日星期三的報告中重申了對沃特世的 “持有” 評級。有兩位股票研究分析師對該股票給予了強力買入評級，七位給予了買入評級，十位對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，沃特世目前的共識評級為 “適度買入”，平均目標價為 392.19 美元。</p>
<p><strong>查看我們對沃特世的最新股票分析</strong></p>
<h2>關於沃特世</h2>
<p>（免費報告）</p>
<p>沃特世公司在亞洲、美洲和歐洲提供分析工作流程解決方案。它通過兩個部門運營：沃特世和 TA。該公司設計、製造、銷售和服務高效和超高效液相色譜以及質譜（MS）技術系統和支持產品，包括色譜柱、其他消耗品和保修後服務計劃。</p>
<h2>閲讀更多</h2>
<ul>
<li>我們更看好的五隻股票比沃特世更好</li>
<li>內部人士買入解析：投資者需要知道什麼</li>
<li>ServiceNow 的 70 億美元賭注：恐慌還是機會？</li>
<li>什麼是股息收割策略，投資者如何從中獲利？</li>
<li>戴爾和惠普正在漲價——投資者應注意</li>
<li>動盪市場中的資產配置策略</li>
<li>為什麼 DLocal 是 2026 年值得關注的頂級新興市場金融科技股票</li>
</ul>
<p><strong>想看看其他對沖基金持有的 WAT 股票嗎？</strong> 訪問 HoldingsChannel.com 獲取沃特世公司（NYSE:WAT - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在沃特世嗎？</h2>
<p>在考慮沃特世之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而沃特世並不在名單上。</p>
<p>雖然沃特世目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

沃特世

<p>Armstrong Henry H Associates Inc. 在第三季度減少了對沃特世公司的持股，降幅為 47.7%，目前持有 4,268 股，價值 128 萬美元。其他機構投資者也調整了在沃特世的持倉，先鋒集團、Alliancebernstein、State Street 和 Geode Capital 均增加了他們的持股。沃特世的股票開盤價為 385.31 美元，市值為 229.4 億美元。分析師的評級意見不一，普遍共識為 “適度買入”，平均目標價為 392.19 美元</p>

<p>Armstrong Henry H Associates Inc. trimmed its position in shares of Waters Corporation (NYSE:WAT - Free Report) by 47.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,268 shares of the medical instruments supplier's stock after selling 3,889 shares during the period. Armstrong Henry H Associates Inc.'s holdings in Waters were worth $1,280,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>根據 Armstrong Henry H Associates Inc.在最近向證券交易委員會提交的 13F 文件，該公司在第三季度將其在沃特世（NYSE:WAT - 免費報告）股份的持倉削減了 47.7%。該機構投資者在此期間出售了 3,889 股後，持有 4,268 股該醫療儀器供應商的股票。Armstrong Henry H Associates Inc.在沃特世的持股在最近的報告期末價值為 1,280,000 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷倫科技受益於對永久化學品的打擊</li>
</ul>
</div><p>Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Waters by 1.9% in the 2nd quarter. Vanguard Group Inc. now owns 7,410,763 shares of the medical instruments supplier's stock valued at $2,586,653,000 after buying an additional 138,511 shares during the last quarter. Alliancebernstein L.P. lifted its stake in shares of Waters by 31.0% in the second quarter. Alliancebernstein L.P. now owns 4,021,358 shares of the medical instruments supplier's stock worth $1,403,615,000 after acquiring an additional 950,687 shares in the last quarter. State Street Corp boosted its holdings in Waters by 1.4% in the second quarter. State Street Corp now owns 2,676,198 shares of the medical instruments supplier's stock valued at $934,100,000 after purchasing an additional 37,763 shares during the last quarter. Geode Capital Management LLC grew its stake in Waters by 2.8% during the 2nd quarter. Geode Capital Management LLC now owns 1,552,399 shares of the medical instruments supplier's stock valued at $539,606,000 after purchasing an additional 42,202 shares in the last quarter. Finally, Norges Bank purchased a new stake in Waters during the 2nd quarter worth approximately $266,384,000. Institutional investors and hedge funds own 94.01% of the company's stock.</p>
<div class="lb-trans"><p>其他機構投資者最近也增加或減少了在該公司的股份。先鋒集團在第二季度將其在沃特世的持倉提高了 1.9%。先鋒集團目前持有 7,410,763 股該醫療儀器供應商的股票，價值為 2,586,653,000 美元，此前在上個季度又購買了 138,511 股。Alliancebernstein L.P.在第二季度將其在沃特世的股份提高了 31.0%。Alliancebernstein L.P.目前持有 4,021,358 股該醫療儀器供應商的股票，價值為 1,403,615,000 美元，此前在上個季度又收購了 950,687 股。道富銀行在第二季度將其在沃特世的持股提高了 1.4%。道富銀行目前持有 2,676,198 股該醫療儀器供應商的股票，價值為 934,100,000 美元，此前在上個季度又購買了 37,763 股。Geode Capital Management LLC 在第二季度將其在沃特世的股份提高了 2.8%。Geode Capital Management LLC 目前持有 1,552,399 股該醫療儀器供應商的股票，價值為 539,606,000 美元，此前在上個季度又購買了 42,202 股。最後，挪威銀行在第二季度購買了沃特世的新股份，價值約為 266,384,000 美元。機構投資者和對沖基金持有該公司 94.01% 的股份。</p>
</div><h2>Waters Stock Performance</h2>
<div class="lb-trans"><h2>沃特世股票表現</h2>
</div><p>WAT stock opened at $385.31 on Tuesday. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56. The stock has a market capitalization of $22.94 billion, a price-to-earnings ratio of 35.41, a PEG ratio of 3.50 and a beta of 1.16. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.08 and a current ratio of 1.53. The stock's fifty day moving average is $369.47 and its two-hundred day moving average is $333.65.</p>
<div class="lb-trans"><p>沃特世股票週二開盤價為 385.31 美元。沃特世的 1 年最低價為 275.05 美元，1 年最高價為 423.56 美元。該股票的市值為 229.4 億美元，市盈率為 35.41，PEG 比率為 3.50，貝塔值為 1.16。該公司的債務與股本比率為 0.41，速動比率為 1.08，流動比率為 1.53。該股票的 50 日移動平均線為 369.47 美元，200 日移動平均線為 333.65 美元。</p>
</div><ul>
<li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療股票沃特世、安捷倫、Illumina 顯示增長潛力</li>
</ul>
</div><p>Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a net margin of 20.89% and a return on equity of 36.59%. On average, research analysts predict that Waters Corporation will post 12.86 EPS for the current year.</p>
<div class="lb-trans"><p>沃特世（NYSE:WAT - 獲取免費報告）最近在 5 月 19 日星期四發佈了季度財報。該醫療儀器供應商報告本季度每股收益為 2.29 美元。該業務本季度的收入為 6.0855 億美元。沃特世的淨利潤率為 20.89%，股本回報率為 36.59%。研究分析師平均預測沃特世將在本年度發佈 12.86 的每股收益。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several equities analysts have recently commented on WAT shares. Rothschild Redb upgraded Waters to a &#34;strong-buy&#34; rating in a research note on Wednesday, October 8th. Morgan Stanley started coverage on shares of Waters in a report on Monday, December 1st. They set an &#34;equal weight&#34; rating and a $423.00 price objective for the company. TD Cowen upped their target price on shares of Waters from $345.00 to $390.00 and gave the company a &#34;hold&#34; rating in a research note on Wednesday, November 5th. Redburn Partners set a $390.00 price target on shares of Waters in a research report on Wednesday, October 8th. Finally, Cowen reissued a &#34;hold&#34; rating on shares of Waters in a report on Wednesday, November 5th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Waters currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $392.19.</p>
<div class="lb-trans"><p>幾位股票分析師最近對 WAT 股票發表了評論。羅斯柴爾德紅寶石在 10 月 8 日星期三的研究報告中將沃特世的評級上調至 “強力買入”。摩根士丹利在 12 月 1 日星期一的報告中開始覆蓋沃特世的股票。他們為該公司設定了 “持平” 的評級和 423.00 美元的目標價。TD Cowen 在 11 月 5 日星期三的研究報告中將沃特世的目標價從 345.00 美元上調至 390.00 美元，並給予該公司 “持有” 評級。Redburn Partners 在 10 月 8 日星期三的研究報告中為沃特世設定了 390.00 美元的目標價。最後，Cowen 在 11 月 5 日星期三的報告中重申了對沃特世的 “持有” 評級。有兩位股票研究分析師對該股票給予了強力買入評級，七位給予了買入評級，十位對該公司的股票給予了持有評級。根據 MarketBeat.com 的數據，沃特世目前的共識評級為 “適度買入”，平均目標價為 392.19 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Waters</strong></p>
<div class="lb-trans"><p><strong>查看我們對沃特世的最新股票分析</strong></p>
</div><h2>About Waters</h2>
<div class="lb-trans"><h2>關於沃特世</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.</p>
<div class="lb-trans"><p>沃特世公司在亞洲、美洲和歐洲提供分析工作流程解決方案。它通過兩個部門運營：沃特世和 TA。該公司設計、製造、銷售和服務高效和超高效液相色譜以及質譜（MS）技術系統和支持產品，包括色譜柱、其他消耗品和保修後服務計劃。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>閲讀更多</h2>
</div><ul>
<li>Five stocks we like better than Waters</li>
<li>Insider Buying Explained: What Investors Need to Know</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>Dell and HP Are Raising Prices—And Investors Should Take Note</li>
<li>Asset Allocation Strategies in Volatile Markets</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比沃特世更好</li>
<li>內部人士買入解析：投資者需要知道什麼</li>
<li>ServiceNow 的 70 億美元賭注：恐慌還是機會？</li>
<li>什麼是股息收割策略，投資者如何從中獲利？</li>
<li>戴爾和惠普正在漲價——投資者應注意</li>
<li>動盪市場中的資產配置策略</li>
<li>為什麼 DLocal 是 2026 年值得關注的頂級新興市場金融科技股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding WAT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 WAT 股票嗎？</strong> 訪問 HoldingsChannel.com 獲取沃特世公司（NYSE:WAT - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=WAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Waters Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在沃特世嗎？</h2>
</div><p>Before you consider Waters, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮沃特世之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而沃特世並不在名單上。</p>
</div><p>While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然沃特世目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Armstrong Henry H Associates Inc. 出售了沃特世公司 $WAT 的股票